Title of article :
Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary Intervention Original Research Article
Author/Authors :
Ehtisham Mahmud، نويسنده , , Jeffrey J. Cavendish، نويسنده , , Sotirios Tsimikas، نويسنده , , Lawrence Ang، نويسنده , , Cuong Nguyen، نويسنده , , Guilherme Bromberg-Marin، نويسنده , , Guido Schnyder، نويسنده , , Shahin Keramati، نويسنده , , Vachaspathi Palakodeti، نويسنده , , William F. Penny، نويسنده , , Anthony N. DeMaria، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Abstract :
Objectives
This study sought to determine the factors associated with suboptimal platelet inhibition (PI) with single- and double-bolus eptifibatide during percutaneous coronary intervention (PCI).
Background
Although PI ≥ 95% measured 10 min after glycoprotein IIb/IIIa inhibitor therapy is associated with improved outcomes following PCI, this level of PI often is not achieved.
Methods
We prospectively studied 150 patients undergoing PCI with single-bolus eptifibatide (180 μg/kg) (n = 100) and double-bolus eptifibatide (180 μg/kg administered 10 min apart) (n = 50) followed by standard infusion (2 μg/kg/min). Measuring platelet aggregation at baseline and at 10 min and 30 to 45 min after eptifibatide bolus, patients were classified as optimal responders (OPT) (≥95% PI) or suboptimal responders (sub-OPT) (<95% PI) based on 10-min PI after final bolus.
Results
Suboptimal PI was achieved in 61% of patients with single-bolus eptifibatide and in 36% with double-bolus eptifibatide. In the single-bolus group, sub-OPT had higher fibrinogen levels (324 ± 85 mg/dl vs. 259 ± 49 mg/dl, p = 0.0002), platelet counts (221 ± 70 vs. 186 ± 47, p = 0.008), and white blood cell counts (7.7 ± 2.3 vs. 6.6 ± 1.9, p = 0.02). In the double-bolus group, sub-OPT also had higher fibrinogen levels (324 ± 68 mg/dl vs. 278 ± 53 mg/dl, p = 0.01) and were more likely to be smokers (38.9% vs. 9.4%, p = 0.01). Multivariable analysis showed that fibrinogen level was the only independent predictor of suboptimal PI, with fibrinogen cutoffs at 375 and 325 mg/dl predicting suboptimal PI (single-bolus: 100% and 90.0%, respectively; double-bolus: 100% and 60%, respectively) with both doses.
Conclusions
During PCI, both single- and double-bolus eptifibatide provide suboptimal PI in a substantial proportion of patients. A fibrinogen level >375 mg/dl is a strong predictor of suboptimal PI.
Keywords :
CK , PCI , C-reactive protein , Creatine kinase , PI , ROC , Glycoprotein , CRP , mace , Percutaneous coronary intervention , GP , major adverse cardiac events , receiver-operator characteristic , OPT , optimal responders , platelet inhibition , sub-OPT , suboptimal responders
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)